Niagen Bioscience, Inc. (NAGE) — Cash Flow Reinvestment Rate
Niagen Bioscience, Inc. (NAGE) has a Cash Flow Reinvestment Rate of 0.01x as of September 2025, reinvesting $48.00K (capex $24.00K plus investments $-24.00K) from operating cash flow of $3.69 Million. Explore Niagen Bioscience, Inc. capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Niagen Bioscience, Inc. Cash Flow Reinvestment Rate (2023–2024)
Historical reinvestment intensity for Niagen Bioscience, Inc. across 2 annual periods. Also explore Niagen Bioscience, Inc. asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Niagen Bioscience, Inc. (2023–2024)
Year-by-year capital reinvestment analysis for Niagen Bioscience, Inc.. For live market cap and broader valuation context, see Niagen Bioscience, Inc. (NAGE) total market value.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.03x | $306.00K | $12.11 Million | $163.00K | ▼ -38.2% |
| 2023 | 0.04x | $291.00K | $7.12 Million | $148.00K | — |